CNNM2 c.*7935T>C

Variant ID: 10-104844872-T-C

NM_017649.4(CNNM2):c.*7935T>C

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs7092200
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.

Pharmacogenetics And Genomics
Li, Liang L; Schaid, Daniel J DJ; Fridley, Brooke L BL; Kalari, Krishna R KR; Jenkins, Gregory D GD; Abo, Ryan P RP; Batzler, Anthony A; Moon, Irene I; Pelleymounter, Linda L; Eckloff, Bruce W BW; Wieben, Eric D ED; Sun, Zhifu Z; Yang, Ping P; Wang, Liewei L
Publication Date: 2012-02

Variant appearance in text: rs7092200
PubMed Link: 22173087
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

The Journal Of Pharmacology And Experimental Therapeutics
Mitra, Amit K AK; Crews, Kristine R KR; Pounds, Stanley S; Cao, Xueyuan X; Feldberg, Tanya T; Ghodke, Yogita Y; Gandhi, Varsha V; Plunkett, William W; Dolan, M Eileen ME; Hartford, Christine C; Raimondi, Susana S; Campana, Dario D; Downing, James J; Rubnitz, Jeffrey E JE; Ribeiro, Raul C RC; Lamba, Jatinder K JK
Publication Date: 2011-10

Variant appearance in text: rs7092200
PubMed Link: 21712425
Variant Present in the following documents:
  • Main text
View BVdb publication page